NasdaqCM - Nasdaq Real Time Price USD

NeuroOne Medical Technologies Corporation (NMTC)

Compare
0.9638 -0.0361 (-3.62%)
As of 3:17 PM EDT. Market Open.
Currency in USD All numbers in thousands
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Total Revenue
3,922.4990
1,952.4410
171.1690
178.1460
--
Cost of Revenue
2,790.2390
1,495.9240
241.9630
275.8950
--
Gross Profit
1,132.2600
456.5170
-70.7940
-97.7490
--
Operating Expense
13,367.4780
12,411.7670
9,959.9710
10,120.4620
4,902.2610
Operating Income
-12,235.2180
-11,955.2500
-10,030.7650
-10,218.2110
-4,902.2610
Net Non Operating Interest Income Expense
--
--
--
-3.0530
-7,524.5810
Other Income Expense
132.5820
95.7590
31.1520
273.0960
-1,213.3180
Pretax Income
-12,102.6360
-11,859.4910
-9,999.6130
-9,948.1680
-13,640.1600
Net Income Common Stockholders
-12,102.6360
-11,859.4910
-9,999.6130
-9,948.1680
-13,640.1600
Diluted NI Available to Com Stockholders
-12,102.6360
-11,859.4910
-9,999.6130
-9,948.1680
-13,640.1600
Basic EPS
-0.48
-0.65
-0.63
-0.93
-2.52
Diluted EPS
-0.48
-0.65
-0.63
-0.93
-2.52
Basic Average Shares
24,875.5760
18,121.1080
15,998.5670
10,696.7990
5,415.4240
Diluted Average Shares
24,875.5760
18,121.1080
15,998.5670
10,696.7990
5,415.4240
Total Operating Income as Reported
-12,235.2180
-11,955.2500
-10,030.7650
-10,218.2110
-4,902.2610
Total Expenses
16,157.7170
13,907.6910
10,201.9340
10,396.3570
4,902.2610
Net Income from Continuing & Discontinued Operation
-12,102.6360
-11,859.4910
-9,999.6130
-9,948.1680
-13,640.1600
Normalized Income
-12,102.6360
-11,859.4910
-9,999.6130
-9,950.1420
-12,426.8420
Interest Expense
--
--
--
3.0530
7,524.5810
Net Interest Income
--
--
--
-3.0530
-7,524.5810
EBIT
-12,235.2180
-11,955.2500
-10,030.7650
-9,945.1150
-6,115.5790
EBITDA
-11,990.0450
-11,755.9840
-9,912.1450
-9,864.3670
-6,067.9700
Reconciled Cost of Revenue
2,790.2390
1,495.9240
241.9630
275.8950
--
Reconciled Depreciation
245.1730
199.2660
118.6200
80.7480
47.6090
Net Income from Continuing Operation Net Minority Interest
-12,102.6360
-11,859.4910
-9,999.6130
-9,948.1680
-13,640.1600
Total Unusual Items Excluding Goodwill
--
--
--
1.9740
-1,213.3180
Total Unusual Items
--
--
--
1.9740
-1,213.3180
Normalized EBITDA
-11,990.0450
-11,755.9840
-9,912.1450
-9,866.3410
-4,854.6520
9/30/2020 - 3/15/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers